Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ARMP
#2996
Armata Pharmaceuticals, Inc. Common Stock
12.585
0
USD
+4.53%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.53%
Monthly Change
+18.84%
6 month change
+53.99%
Year Change
+53.99%
Previous Close
12.040
0
Open
12.839
2
Bid
Ask
Low
12.280
0
High
12.839
2
Volume
12
Markets
US Stock Market
Healthcare
ARMP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
24.94 M
30.73 M
36.14 M
36.15 M
36.18 M
36.63 M
—
Valuation ratios
Enterprise value
64.8 M
158.1 M
24.91 M
180.84 M
113.08 M
478.29 M
865.42 M
Price to earnings ratio
-2.21
-5.71
-1.02
-1.62
-2.08
-1.31
-10.63
Price to sales ratio
—
29.52
6.85
24.69
21.12
46.41
95.22
Price to cash flow ratio
-2.68
-5.6
-1.16
-2.36
-2.91
-8.83
-18.81
Price to book ratio
2.6
5.2
1.05
-3.49
-2.28
-1.04
-2.27
Enterprise value to EBITDA ratio
—
-6.98
-0.69
-5.48
-3.53
-14.51
-26.82
Profitability ratios
Return on assets %
-0.56
-0.33
-0.39
-0.7
-0.22
-2.26
-2.19
Return on equity %
-1.18
-0.91
-1.02
2.15
0.39
0.8
1.2
Return on invested capital %
-309.25
-209.97
-203.92
16.62 K
-83.38
-128.47
-84.84
Gross margin %
—
100
100
100
100
100
400
Operating margin %
—
-532.45
-670.77
-902.85
-820.18
-747.02
-3 928.7
EBITDA margin %
—
-506.33
-654.58
-881.39
-794.57
-715.8
-3 763.39
Net margin %
—
-517.55
-670.24
-1 524.51
-365.6
-3 544.03
-15.84 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
1.62
3.11
1.09
1.16
0.23
1.19
1.5
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.08
0.07
0.05
0.06
0.06
0.06
Solvency ratios
Debt to assets ratio
—
—
—
0.84
0.64
3.34
5.54
Debt to equity ratio
—
—
—
-2.57
-1.15
-1.18
-3.88
Long term debt to total assets ratio
—
—
—
0.84
0.64
3.34
4.78
Long term debt to total equity ratio
—
—
—
-2.57
-1.15
-1.18
-2.83
Per share metrics
Operating cash flow per share
-1.11
-0.98
-0.95
-1.31
-0.64
-0.71
-0.63
EBIT per share
—
-0.99
-1.08
-1.13
-0.72
-1.01
-0.92
EBITDA per share
—
-0.94
-1.05
-1.11
-0.7
-0.97
-0.88
Total debt per share
—
—
—
2.28
0.94
7.09
11.64
Cash per share
0.59
0.43
0.43
0.37
0.16
0.24
0.96
Net current asset value per share
0.66
0.62
0.79
0.53
0.19
0.29
1.19
Tangible book value per share
0.31
0.48
0.65
-1.27
-1.05
-6.41
-12.86
Working capital per share
0.25
0.42
0.06
0.07
-0.63
0.05
-8.1
Book value per share
1.15
1.05
1.05
-0.89
-0.81
-6.03
-11.5
News
H.C. Wainwright lowers Armata Pharmaceuticals stock price target to $15
Armata Pharmaceuticals stock gains on FDA designation
FDA grants QIDP status to Armata’s staph infection treatment
Innoviva stock gains BTIG coverage with buy rating on royalty windfall
Armata to advance bacteriophage therapy to phase 3 for S. aureus
Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating
Armata Pharma earnings missed by $0.24, revenue fell short of estimates
Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
Armata Pharmaceuticals commissions phage manufacturing facility
Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates